Rome Zachary's Form 4 filing
Kuvatris Therapeutics, Inc. (PXMD) · filed Aug 30, 2023
- Accession no.
- 0001062993-23-017282
- Filed
- Aug 30, 2023, 4:09 PM ET
- Trade date
- Aug 28-30, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $12.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rome ZacharyCIK 0001809611 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2023 | Common Stock | SSaleDisposed | −12,000 | $0.4885F2 | −$5,862 | 307,284 | Direct | |
| Aug 29, 2023 | Common Stock | SSaleDisposed | −8,792 | $0.4842F3 | −$4,257.09 | 298,492 | Direct | |
| Aug 30, 2023 | Common Stock | SSaleDisposed | −4,801 | $0.4655 | −$2,234.87 | 293,691 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The sale price represents the weighted average sale price of the shares sold ranging from $0.4703 to $0.5005 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Referenced by the price of 1 transaction in Table I.
- F3
The sale price represents the weighted average sale price of the shares sold ranging from $0.4806 to $0.5025 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Referenced by the price of 1 transaction in Table I.